Active Not RecruitingNCT03713424
Clavulanic acid and brain responses related to smoking
About this title
Read the official source — NCT03713424Medication studyAges 18–65United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- ColumbiaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 26, 2019
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- University of Missouri-Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03713424
- Official title
Show the full official title
An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Columbia
Questions about this study
Who is behind this study?
The study sponsor is University of Missouri-Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including Clavulanic Acid and Placebo oral capsule.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
